Mission Therapeutics Ltd. announced that it has received £25.2 million in a round of funding co-led by returning investors Pfizer Venture Investments LLC, Sofinnova Partners SAS, Roche Venture Fund, SR One Capital Management, LP, IP Group Plc, Rosetta Capital Limited on March 14, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.72 GBX | -1.66% | +0.72% | -15.75% |
11:31am | IP Group's Hysata Raises $111 Million to Boost Production Capacity | MT |
05-08 | Home REIT cuts borrowings, Genflow shares restored | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.75% | 638M | |
-4.12% | 116B | |
+0.88% | 92.96B | |
+13.72% | 68.72B | |
+17.46% | 64.48B | |
+10.49% | 43.01B | |
+12.14% | 42.31B | |
+18.45% | 35.83B | |
+3.53% | 24.9B | |
-2.76% | 22.69B |
- Stock Market
- Equities
- IPO Stock
- News IP Group Plc
- Mission Therapeutics Ltd. announced that it has received £25.2 million in funding from Pfizer Venture Investments LLC, Sofinnova Partners SAS, Roche Venture Fund, SR One Capital Management, LP, IP Group Plc, Rosetta Capital Limited